[HTML][HTML] Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases
H Mostafavi Abdolmaleky, JR Zhou - Antioxidants, 2024 - mdpi.com
Gut dysbiosis, resulting from an imbalance in the gut microbiome, can induce excessive
production of reactive oxygen species (ROS), leading to inflammation, DNA damage …
production of reactive oxygen species (ROS), leading to inflammation, DNA damage …
Gut aging: a wane from the normal to repercussion and gerotherapeutic strategies
JK Abankwah, Y Wang, J Wang, SE Ogbe, L Dal Pozzo… - Heliyon, 2024 - cell.com
Globally, age-related diseases represent a significant public health concern among the
elderly population. In aging, healthy organs and tissues undergo structural and functional …
elderly population. In aging, healthy organs and tissues undergo structural and functional …
[HTML][HTML] Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model
P Corbetta, E Lonati, S Pagliari, M Mauri… - International Journal of …, 2024 - mdpi.com
Inflammatory bowel disease (IBD) incidence has increased in the last decades due to
changes in dietary habits. IBDs are characterized by intestinal epithelial barrier disruption …
changes in dietary habits. IBDs are characterized by intestinal epithelial barrier disruption …
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation
Activation of the NLRP3 inflammasome in response to either exogenous (PAMPs) or
endogenous (DAMPs) stimuli results in the production of IL-18, caspase-1 and IL-1β. These …
endogenous (DAMPs) stimuli results in the production of IL-18, caspase-1 and IL-1β. These …
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells
R Mancuso, LA Citterio, S Agostini, I Marventano… - Pharmaceuticals, 2023 - mdpi.com
The anti-hyperglycemic drug glibenclamide (Glb) might represent an interesting therapeutic
option in human neurodegenerative diseases because of its anti-inflammatory activity and …
option in human neurodegenerative diseases because of its anti-inflammatory activity and …
Targeting programmed cell death in inflammatory bowel disease through natural products: New insights from molecular mechanisms to targeted therapies
M Wang, Z Wang, Z Li, Y Qu, J Zhao… - Phytotherapy …, 2024 - Wiley Online Library
Inflammatory bowel disease (IBD) is an autoimmune disorder primarily characterized by
intestinal inflammation and recurrent ulceration, leading to a compromised intestinal barrier …
intestinal inflammation and recurrent ulceration, leading to a compromised intestinal barrier …
Microbiome-based therapies for Parkinson's disease
The human gut microbiome dysbiosis plays an important role in the pathogenesis of
Parkinson's disease (PD). The bidirectional relationship between the enteric nervous system …
Parkinson's disease (PD). The bidirectional relationship between the enteric nervous system …
[PDF][PDF] ENFLAMATUAR BAĞIRSAK HASTALIĞI VE TIBBİ BİTKİLER: GÜNCEL BİR GÖZDEN GEÇİRME.
E BAYIR, G ELGİN CEBE - Journal of Faculty of Pharmacy of …, 2024 - researchgate.net
Amaç: Enflamatuar bağırsak hastalığı (EBH), ülserasyon, kanama, sıvı ve elektrolit kaybı ile
karakterize, atak ve remisyon dönemlerinden oluşan gastrointestinal sistemin (GİS) kronik …
karakterize, atak ve remisyon dönemlerinden oluşan gastrointestinal sistemin (GİS) kronik …
ENFLAMATUAR BAĞIRSAK HASTALIĞI VE TIBBİ BİTKİLER: GÜNCEL BİR GÖZDEN GEÇİRME
Amaç: Enflamatuar bağırsak hastalığı (EBH), ülserasyon, kanama, sıvı ve elektrolit kaybı ile
karakterize, atak ve remisyon dönemlerinden oluşan gastrointestinal sistemin (GİS) kronik …
karakterize, atak ve remisyon dönemlerinden oluşan gastrointestinal sistemin (GİS) kronik …